Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EPM2AIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
AP1G2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTC-338M12.4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CCDC84 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPIPA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAPPC10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GABBR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6758 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPA2B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKZF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL32P3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100288152 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK5RAP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFB8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCARNA13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CIRBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on